Beneficial effects of erythropoietin on airway histology in a murine model of chronic asthma

Allergologia et Immunopathologia

Volumn 40, Issue 2, 2012, Pages 75-80

  Karaman, M ^a   Firinci, F ^a   Kiray, M ^a   Tuncel, T ^a   Bagriyanik, A ^a   Yilmaz, O ^a   Uzuner, N ^a   Karaman, O ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Chronic asthma; Erythropoietin; Mouse; Treatment

Indexed keywords

DEXAMETHASONE; OVALBUMIN; RECOMBINANT ERYTHROPOIETIN; SODIUM CHLORIDE;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; ELECTRON MICROSCOPY; FEMALE; HISTOLOGY; HUMAN; LOW DRUG DOSE; MAST CELL; MICROSCOPY; MOUSE; NONHUMAN; TREATMENT RESPONSE;

AIRWAY REMODELING; ANIMALS; ASTHMA; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; HUMANS; IMMUNIZATION; INJECTIONS, INTRAPERITONEAL; LUNG; MAST CELLS; MICE; MICE, INBRED BALB C; OVALBUMIN;

EID: 84857655706     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2011.02.010     Document Type: Article

References (31)

1. Hansel T.T., Barnes P.J. Novel drugs for treating asthma. Curr Allergy Asthma Rep 2001, 1:164-173.
2. Kumar R.K. Understanding airway wall remodeling in asthma: a basis for improvements in therapy?. Pharmacol Ther 2001, 91:93-104.
3. Tagaya E., Tamaoki J. Mechanisms of airway remodeling in asthma. Allergol Int 2007, 56:33-340.
4. Kips J.C., Paulwels R.A. Airway wall remodelling: does it occur and what does it mean?. Clin Exp Allergy 1999, 29:1457-1466.
5. Sumi Y., Hamid Q. Airway remodeling in asthma. Allergol Int 2007, 56:341-348.
6. Payne D.N., Rogers A.V., Adelroth E., Bandi V., Guntupalli K.K., Bush A., et al. Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med 2003, 167:78-82.
7. Arcasoy M.O. The non-haematopoietic biological effects of erythropoietin. Br J Haematol 2008, 141:14-31.
8. Bany-Mohammad F.M., Slivka S., Hallman M. Recombinant human erythropoietin: possible role as an antioxidant in premature rabbits. Pediatr Res 1996, 40:381-387.
9. Jakkula M., Le Cras T.D., Gebb S., Hirth K.P., Tuder R.M., Voelkel N.F., et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 2000, 279:600-607.
10. Prutchi Sagiv S., Lifshitz L., Orkin R., Mittelman M., Neumann D. Erythropoietin effects on dendritic cells: potential mediators in its function as an immunomodulator?. Exp Hematol 2008, 36:1682-1690.
11. Strunk T., Härtel C., Temming P., Matzke N., Zimmer J., Schultz C. Erythropoietin inhibits cytokine production of neonatal and adult leukocytes. Acta Paediatr 2008, 97:16-20.
12. Temelkovski J., Hogan S.P., Shepherd D.P., Foster P.S., Kumar R.K. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methocholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998, 53:849-856.
13. Olmez D., Babayigit A., Uzuner N., Erbil G., Karaman O., Yilmaz O., et al. Efficacy of sulphasalazine on lung histopathology in a murine model of chronic asthma. Exp Lung Res 2008, 34:501-511.
14. Yoshimi M., Maeyama T., Yamada M., Hamada N., Fukumoto J., Kawaguchi T., et al. Recombinant human erythropoietin reduces epithelial cell apoptosis and attenuates bleomycin-induced pneumonitis in mice. Respirology 2008, 13:639-645.
15. Wang X.L., Xue X.D. Anti-inflammatory effects of erythropoietin on hyperoxia-induced bronchopulmonary dysplasia in newborn rats. Zhonghua Er Ke Za Zhi 2009, 47:446-451. [abstract].
16. Bergeron C., Boulet L.P. Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. Chest 2006, 129:1068-1087.
17. Mauad T., Bel E.H., Sterk P.J. Asthma therapy and airway remodeling. J Allergy Clin Immunol 2007, 120:997-1009.
18. Yamauchi K., Inoue H. Airway remodeling in asthma and irreversible airflow limitation-ECM deposition in airway and possible therapy for remodeling. Allergol Int 2007, 56:321-329.
19. Bourdin A., Neveu D., Vachier I., Paganin F., Godard P., Chanez P. Specificity of basement membrane thickening in severe asthma. J Allergy Clin Immunol 2007, 119:1367-1374.
20. Yu H., Bauer B., Lipke G.K., Phillips R.L., Van Zant G. Apoptosis and hematopoiesis in murine fetal liver. Blood 1993, 81:373-384.
21. Crawford J., Cella D., Cleeland C.S., Cremieux P.Y., Demetri G.D., Sarokhan B.J., et al. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer 2002, 95:888-895.
22. Dzietko M., Felderhoff-Mueser U., Sifringer M., Krutz B., Bittigau P., Thor F., et al. Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity. Neurobiol Dis 2004, 15:177-187.
23. Sekiguchi Y., Kikuchi S., Myers R.R., Campana W.M. Erythropoietin inhibits spinal neuronal apoptosis and pain following nerve root crush. Spine 2003, 28:2577-2584.
24. Calvillo L., Latini R., Kajstura J., Leri A., Anversa P., Ghezzi P., et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci 2003, 100:4802-4806.
25. Vesey D.A., Cheung C., Pat B., Endre Z., Gobé G., Johnson D.W., et al. Erythropoietin protects against ischemic acute renal injury. Nephrol Dial Transpl 2004, 19:348-355.
26. Brines M., Cerami A. Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise. Kidney Int 2006, 70:246-250.
27. Christman J.W., Sadikot R.T., Blackwell T.S. The role of nuclear factor-kappa B in pulmonary diseases. Chest 2000, 117:1482-1487.
28. Desmet C., Gosset P., Pajak B., Cataldo D., Bentires-Alj M., Lekeux P., et al. Selective blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma. J Immunol 2004, 173:5766-5775.
29. Hancox R.J., Stevens D.A., Adcock I.M., Barnes P.J., Taylor D.R. Effects of inhaled beta agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma. Thorax 1999, 54:488-492.
30. Nairz M., Schroll A., Moschen A.R., Sonnweber T., Theurl M., Theurl I., et al. Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-κB-inducible immune pathways. Immunity 2011, 34:61-74.
31. Cuzzocrea S., Mazzon E., di Paola R., Genovese T., Patel N.S., Britti D., et al. Erythropoietin reduces the degree of arthritis caused by type II collagen in the mouse. Arthritis Rheum 2005, 52:940-950.